Zydus Lifesciences (ZYDUSLIFE) Share Price rises 2.08% as stock trades at Rs 1,138.25

Zydus Lifesciences Share Price is in focus after the stock rose 2.08% and last traded at Rs 1,138.25, with market capitalisation at Rs 1,11,231.65 crore as of 12 October 2026 at 2:23:03 PM IST. The move placed Zydus Lifesciences Share Price among the notable healthcare movers in the Indian Stock Market Today, even though a company-specific catalyst is not established. Univest data confirms the move itself, though no company-specific trigger has been identified. For readers tracking Zydus Lifesciences Share Price Today, the key point is the clean intraday price action: the stock opened above the previous close, moved to the day’s high of Rs 1,138.25 and held near that level. Investors watching Zydus Lifesciences Stock News can use this share price rise as the starting point for a broader stock analysis and fundamental analysis of valuation, profitability and sector standing.

Zydus Lifesciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,138.25
Previous Close	Rs 1,115.1
Today's Move	Rs 23.15 (+2.08%)
Open	Rs 1,116.1
High	Rs 1,138.25
Low	Rs 1,108
Market Capitalisation	Rs 1,11,231.65 crore
Market Cap Category	Large Cap

Zydus Lifesciences Ltd. (ZYDUSLIFE) rose to Rs 1,138.25 from the previous close of Rs 1,115.1, a move of Rs 23.15 or 2.08%. The stock opened at Rs 1,116.1, reached a high of Rs 1,138.25, recorded a low of Rs 1,108.

Zydus Lifesciences Share Price Today shows a straightforward intraday gain. The stock was at Rs 1,138.25, up Rs 23.15 from the previous close of Rs 1,115.10, after opening at Rs 1,116.10 and touching a low of Rs 1,108.00. The day high was Rs 1,138.25, which is also the latest trade. That puts Zydus Lifesciences Share Price in a strong price action position for the day, with the move reflecting a 2.08% rise. In the context of Zydus Lifesciences Share Price Live tracking, the current move is important because it happened without a verified company-specific trigger. According to latest Univest figures, the stock is trading above the previous close and near the day high, which is the main fact pattern behind today’s Zydus Lifesciences Share Price Update. The next section shifts from price action to Zydus Lifesciences Fundamental Analysis.

Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,11,231.65 crore
P/E Ratio	24.65x
P/B Ratio	4.13x
ROE	19.69%
ROCE	21.39%
EPS	Rs 45.24
Book Value Per Share	Rs 270.31
Dividend Yield	0.09%

Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 24.65x, P/B 4.13x, ROE 19.69%, ROCE 21.39%. Read together, these ratios describe the company's position rather than a recommendation.

Zydus Lifesciences Ltd. has a market capitalisation of Rs 1,11,231.65 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.65x, P/B at 4.13x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.5x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	24.65x
Benchmark Median P/E	31.5x
Benchmark Average P/E	47.12x
Benchmark P/E Range	3.56x to 679.32x
Company P/B Ratio	4.13x
Benchmark Median P/B	2.83x
Company ROE	19.69%
Benchmark Median ROE	11.22%
Company ROCE	21.39%
Benchmark Median ROCE	13.1%
Company Market Capitalisation	Rs 1,11,231.65 crore
Benchmark Median Market Cap	Rs 709.64 crore

Zydus Lifesciences Ltd. (ZYDUSLIFE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 24.65x, which is below the benchmark median of 31.5x, a difference of -21.75%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.22%, a difference of +75.49%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.1%, a difference of +63.28%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,21,539.16	34.85	4.87	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,47,576	84.64	14.02	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,77,251.42	81.27	19.75	26.76	19.27
Laurus Labs Ltd.	LAURUSLABS	1,09,796.85	100.42	19.47	18.31	18.2
Cipla Ltd.	CIPLA	1,05,289.78	31.24	2.99	11.83	16

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 24.65x compared with the displayed peer median of 81.27x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 19.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,11,231.65 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Zydus Lifesciences

• Zydus Lifesciences Share Price rose 2.08% to Rs 1,138.25, with the latest trade matching the day high.
• The market cap of Rs 1,11,231.65 crore gives Zydus Lifesciences Share Price size context within healthcare.
• P/E at 24.65 and P/B at 4.13 place Zydus Lifesciences Share Price within a measurable valuation frame.
• ROE of 19.69% and ROCE of 21.39% add return-on-capital context to Zydus Lifesciences Fundamental Analysis.
• The stock is being tracked as part of Zydus Lifesciences Stock News alongside sector benchmarks and peers.

About Zydus Lifesciences

Zydus Lifesciences Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical products and related healthcare offerings, and it is positioned among the larger listed names in its industry by market capitalisation. Zydus Lifesciences Share Price reflects a business that is assessed not only on day-to-day price movement but also on earnings power, book value and return ratios. In this context, Zydus Lifesciences Financial Results and Zydus Lifesciences Stock Analysis are usually read together because the company’s P/E, P/B, EPS, book value, ROE and ROCE provide a fuller view than price alone. Zydus Lifesciences Share News today fits that broader profile: an active stock move in a large healthcare name with meaningful operating metrics behind it. For readers following Zydus Lifesciences Latest News, the company remains relevant because of its size, sector membership and valuation profile.

Frequently Asked Questions

Why is Zydus Lifesciences Share Price rising today?

Ans. Zydus Lifesciences Share Price rose 2.08% to Rs 1,138.25. Univest data confirms the move itself, though no company-specific trigger has been identified. The move is visible in the intraday price pattern.

What is the current Zydus Lifesciences Share Price?

Ans. Zydus Lifesciences Share Price was Rs 1,138.25 at the latest trade as of 12 October 2026 at 2:23:03 PM IST. It moved above the previous close of Rs 1,115.10 during the session.

How much did Zydus Lifesciences Share Price gain today?

Ans. Zydus Lifesciences Share Price gained Rs 23.15, which is a 2.08% rise from the previous close. The stock also touched the day high of Rs 1,138.25, matching its latest traded level.

What is Zydus Lifesciences market capitalisation?

Ans. Zydus Lifesciences has a market capitalisation of Rs 1,11,231.65 crore. That places the company among the larger healthcare names in the same-industry benchmark and gives the share price movement important size context.

Is Zydus Lifesciences Share Price expensive versus peers?

Ans. Zydus Lifesciences Share Price has a P/E of 24.65, which is below the benchmark median of 31.50 and below several listed peers. Its P/B of 4.13 sits near the benchmark average of 4.19.

What do ROE and ROCE show for Zydus Lifesciences Share Price?

Ans. Zydus Lifesciences reports ROE of 19.69% and ROCE of 21.39%. These are both above the same-industry median values, giving Zydus Lifesciences Share Price a strong profitability and capital-efficiency context.

What are the EPS and book value for Zydus Lifesciences?

Ans. EPS is Rs 45.24 and book value is Rs 270.31 for Zydus Lifesciences. These figures help frame Zydus Lifesciences Share Price against earnings per share and accounting net worth per share.

Does Zydus Lifesciences pay a dividend?

Ans. Zydus Lifesciences has a dividend yield of 0.09%. That figure adds income context to Zydus Lifesciences Share Price, although the main story today remains the intraday rise and valuation backdrop.

Track Zydus Lifesciences Share Price on Univest

Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Zydus Lifesciences Share Price on Univest for live price movement, market capitalisation, valuation ratios, 52-week levels and market insights. Univest also helps readers follow Zydus Lifesciences Share Price Today alongside the company’s earnings-linked metrics, sector context and peer comparison, all in one place.